Russell Investments Group, Ltd. Beam Therapeutics Inc. Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 187,845 shares of BEAM stock, worth $4.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
187,845
Previous 169,561 10.78%
Holding current value
$4.97 Million
Previous $3.97 Million 15.86%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$22.57 - $33.14 $412,669 - $605,931
18,284 Added 10.78%
187,845 $4.6 Million
Q2 2024

Aug 08, 2024
BUY
$21.22 - $32.66 $546,054 - $840,439
25,733 Added 17.89%
169,561 $3.97 Million
Q1 2024

May 08, 2024
BUY
$23.46 - $45.07 $143,152 - $275,017
6,102 Added 4.43%
143,828 $4.75 Million
Q4 2023

Feb 05, 2024
BUY
$17.69 - $30.76 $2,034 - $3,537
115 Added 0.08%
137,726 $3.75 Million
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $488,985 - $689,807
21,251 Added 18.26%
137,611 $3.31 Million
Q2 2023

Aug 10, 2023
BUY
$29.32 - $35.99 $222,890 - $273,595
7,602 Added 6.99%
116,360 $3.72 Million
Q1 2023

May 09, 2023
BUY
$30.15 - $48.79 $527,504 - $853,629
17,496 Added 19.17%
108,758 $3.33 Million
Q4 2022

Feb 08, 2023
SELL
$36.73 - $51.6 $29,347 - $41,228
-799 Reduced 0.87%
91,262 $3.57 Million
Q3 2022

Nov 04, 2022
BUY
$39.79 - $70.31 $73,571 - $130,003
1,849 Added 2.05%
92,061 $4.38 Million
Q2 2022

Jul 29, 2022
SELL
$29.86 - $62.36 $238 - $498
-8 Reduced 0.01%
90,212 $3.49 Million
Q1 2022

May 05, 2022
BUY
$53.73 - $82.16 $48,034 - $73,451
894 Added 1.0%
90,220 $5.17 Million
Q4 2021

Jan 21, 2022
BUY
$68.02 - $99.06 $1.24 Million - $1.81 Million
18,303 Added 25.77%
89,326 $7.12 Million
Q3 2021

Nov 08, 2021
BUY
$84.37 - $133.6 $852,643 - $1.35 Million
10,106 Added 16.59%
71,023 $6.18 Million
Q2 2021

Aug 04, 2021
BUY
$64.12 - $128.71 $2.15 Million - $4.32 Million
33,537 Added 122.49%
60,917 $7.84 Million
Q1 2021

May 10, 2021
BUY
$71.28 - $120.75 $1.54 Million - $2.6 Million
21,565 Added 370.85%
27,380 $2.19 Million
Q4 2020

Feb 08, 2021
BUY
$22.24 - $95.63 $129,325 - $556,088
5,815 New
5,815 $474,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.86B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email